scholarly article | Q13442814 |
review article | Q7318358 |
P50 | author | Adrian Ooi | Q82084141 |
P2093 | author name string | David H Song | |
P2860 | cites work | Preoperative bathing or showering with skin antiseptics to prevent surgical site infection | Q24246355 |
Optimizing Safety, Predictability, and Aesthetics in Direct to Implant Immediate Breast Reconstruction: Evolution of Surgical Technique | Q38765543 | ||
Breast reconstruction with tissue expanders: implementation of a standardized best-practices protocol to reduce infection rates | Q39159255 | ||
Timing of radiation and outcomes in implant-based breast reconstruction | Q40364382 | ||
Critical Evaluation of Risk Factors and Early Complications in 564 Consecutive Two-Stage Implant-Based Breast Reconstructions Using Acellular Dermal Matrix at a Single Center | Q40797271 | ||
Advanced age is a predictor of 30-day complications after autologous but not implant-based postmastectomy breast reconstruction | Q41518674 | ||
The fate of breast implants with infections around them | Q41587444 | ||
Chronic biofilm infection in breast implants is associated with an increased T-cell lymphocytic infiltrate: implications for breast implant-associated lymphoma. | Q41669576 | ||
Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee | Q42598934 | ||
Chlorhexidine-Alcohol versus Povidone-Iodine for Surgical-Site Antisepsis | Q43201081 | ||
Effectiveness of various hospital-based solutions against community- acquired methicillin-resistant Staphylococcus aureus | Q43409057 | ||
Evidence-based protocol for infection control in immediate implant-based breast reconstruction | Q43480424 | ||
Breast implant infection caused by Trichosporon beigelii | Q43944150 | ||
Clinical relevance of positive breast periprosthetic cultures without overt infection. | Q44126975 | ||
Postoperative antibiotic prophylaxis for implant-based breast reconstruction with acellular dermal matrix | Q44158755 | ||
Hospital-associated costs due to surgical site infection after breast surgery | Q44310616 | ||
A paradigm shift in U.S. Breast reconstruction: increasing implant rates | Q44767154 | ||
Risk factors and risk scoring tool for infection during tissue expansion in tissue expander and implant breast reconstruction | Q45140643 | ||
Management of the infected or exposed breast prosthesis: a single surgeon's 15-year experience with 69 patients | Q45164647 | ||
A paradigm shift in U.S. breast reconstruction: Part 2. The influence of changing mastectomy patterns on reconstructive rate and method | Q45357696 | ||
An analysis of the motivating and risk factors for conversion from implant-based to total autologous breast reconstruction | Q45377533 | ||
Implant-based breast reconstruction using acellular dermal matrix and the risk of postoperative complications. | Q45906239 | ||
Comparison of implant-based immediate breast reconstruction with and without acellular dermal matrix. | Q46000796 | ||
ASPS clinical practice guideline summary on breast reconstruction with expanders and implants | Q46068403 | ||
Infection following implant-based reconstruction in 1952 consecutive breast reconstructions: salvage rates and predictors of success | Q46120088 | ||
Immediate implant-based breast reconstruction following total skin-sparing mastectomy: defining the risk of preoperative and postoperative radiation therapy for surgical outcomes | Q46153243 | ||
A rare case of silicone mammary implant infection by Streptomyces spp. in a patient with breast reconstruction after mastectomy: taxonomic characterization using molecular techniques | Q46762619 | ||
Incidence of surgical-site infection is not affected by method of immediate breast reconstruction | Q46967579 | ||
Pilot study of directional airflow and containment of airborne particles in the size of Mycobacterium tuberculosis in an operating room | Q47235217 | ||
Effects of an autologous flap combined with an implant for breast reconstruction: an evaluation of 1000 consecutive reconstructions of previously irradiated breasts | Q47576421 | ||
Predicting complications following expander/implant breast reconstruction: an outcomes analysis based on preoperative clinical risk | Q47666407 | ||
Enhancing Patient Outcomes in Aesthetic and Reconstructive Breast Surgery Using Triple Antibiotic Breast Irrigation: Six-Year Prospective Clinical Study | Q29035662 | ||
Reducing Infectious Complications in Implant Based Breast Reconstruction: Impact of Early Expansion and Prolonged Drain Use. | Q30277269 | ||
Lessons learned from the American College of Surgeons National Surgical Quality Improvement Program Database: has centralized data collection improved immediate breast reconstruction outcomes and safety? | Q30838111 | ||
Over Troubled Water: An Outbreak of Infection Due to a New Species of Mycobacterium following Implant-Based Breast Surgery | Q31034195 | ||
Discussion: Over Troubled Water: An Outbreak of Infection Due to a New Species of Mycobacterium following Implant-Based Breast Surgery | Q31034197 | ||
Once is not enough: withholding postoperative prophylactic antibiotics in prosthetic breast reconstruction is associated with an increased risk of infection | Q34079915 | ||
Use of Acellular Dermal Matrix in Postmastectomy Breast Reconstruction: Are All Acellular Dermal Matrices Created Equal? | Q34495328 | ||
In vitro and in vivo investigation of the influence of implant surface on the formation of bacterial biofilm in mammary implants. | Q35133137 | ||
The infected or exposed breast implant: management and treatment strategies | Q35758736 | ||
Breast Implant-Associated Infections: The Role of the National Surgical Quality Improvement Program and the Local Microbiome | Q35822745 | ||
Breast implant infection with Mycobacterium fortuitum group: report of case and review. | Q36261260 | ||
Novel Brucella strain (BO1) associated with a prosthetic breast implant infection | Q36423704 | ||
The role of betadine irrigation in breast augmentation | Q36719135 | ||
The effect of closed-suction drains on the incidence of local wound complications following tissue expander/implant reconstruction: a cohort study | Q36829350 | ||
Decreasing expander breast infection: A new drain care protocol. | Q37249282 | ||
Delayed silicone breast implant infection with Mycobacterium avium-intracellulare | Q37430476 | ||
AlloDerm performance in the setting of prosthetic breast surgery, infection, and irradiation | Q37642434 | ||
Independent risk factors for infection in tissue expander breast reconstruction | Q37642442 | ||
Breast Implant Infections: Is Cefazolin Enough? | Q37784667 | ||
Impact of Chemotherapy on Postoperative Complications After Mastectomy and Immediate Breast Reconstruction | Q37790548 | ||
Acellular dermis-assisted prosthetic breast reconstruction: a systematic and critical review of efficacy and associated morbidity | Q37957634 | ||
Retrospective review of 331 consecutive immediate single-stage implant reconstructions with acellular dermal matrix: indications, complications, trends, and costs | Q37957636 | ||
Extended trimethoprim/sulfamethoxazole prophylaxis for implant reconstruction in the previously irradiated chest wall | Q37970270 | ||
Breast implant infections | Q37979397 | ||
Breast implant infections after surgical reconstruction in patients with breast cancer: assessment of risk factors and pathogens over extended post-operative observation | Q38008487 | ||
Contributing variables to post mastectomy tissue expander infection | Q38012162 | ||
A systematic review of antibiotic use and infection in breast reconstruction: what is the evidence? | Q38042339 | ||
The ever-changing role of biofilms in plastic surgery | Q38215460 | ||
Infections in breast implants: a review with a focus on developing countries. | Q38248387 | ||
Does the use of biopatch devices at drain sites reduce perioperative infectious complications in patients undergoing immediate tissue expander breast reconstruction? | Q38300214 | ||
Assessment of patient factors, surgeons, and surgeon teams in immediate implant-based breast reconstruction outcomes | Q38334531 | ||
Reducing postoperative infections and red breast syndrome in patients with acellular dermal matrix-based breast reconstruction: the relative roles of product sterility and lower body mass index | Q38361263 | ||
Contamination in smooth gel breast implant placement: testing a funnel versus digital insertion technique in a cadaver model | Q38434884 | ||
Efficacy and Safety of Povidone-Iodine Irrigation in Reducing the Risk of Capsular Contracture in Aesthetic Breast Augmentation: A Systematic Review and Meta-Analysis | Q38591409 | ||
Improving wound healing and preventing surgical site complications of closed surgical incisions: a possible role of Incisional Negative Pressure Wound Therapy. A systematic review of the literature | Q38596324 | ||
A Systematic Review and Head-to-Head Meta-Analysis of Outcomes following Direct-to-Implant versus Conventional Two-Stage Implant Reconstruction. | Q38643322 | ||
Nontuberculous mycobacterial breast implant infections. | Q51080328 | ||
A simple barrier drape for breast implant placement. | Q51212959 | ||
Subclinical infection as a possible cause of significant breast capsules. | Q51647088 | ||
Early Results Using Sterilized Acellular Human Dermis (Neoform) in Post-Mastectomy Tissue Expander Breast Reconstruction. | Q51836651 | ||
Infectious complications following breast reconstruction with expanders and implants. | Q51840187 | ||
The effect of reusable versus disposable draping material on infection rates in implant-based breast reconstruction: a prospective randomized trial. | Q53647482 | ||
Traffic flow in the operating room: an explorative and descriptive study on air quality during orthopedic trauma implant surgery | Q57111435 | ||
Protective Effect of Topical Antibiotics in Breast Augmentation | Q62523921 | ||
Listeria infection of silicone breast implant | Q64135319 | ||
Infection following breast reconstruction | Q69802670 | ||
Infection of mammary prostheses: a survey and the question of prevention | Q70763450 | ||
Capsules, Infection, and Intraluminal Antibiotics | Q70808123 | ||
Late Clostridium perfringens breast implant infection after dental treatment | Q71137617 | ||
Detection of subclinical infection in significant breast implant capsules | Q73168387 | ||
Breast implant infection following nipple piercing | Q73408261 | ||
Reduction of potential contamination of breast implants by the use of 'nipple shields' | Q73446550 | ||
Breast implant infection in a cat owner due to Pasteurella multocida | Q74172500 | ||
Complications in postmastectomy breast reconstruction: two-year results of the Michigan Breast Reconstruction Outcome Study | Q74230282 | ||
A meta-analysis of human acellular dermis and submuscular tissue expander breast reconstruction | Q83078587 | ||
Decolonization strategies to control Staphylococcus aureus infections in breast implant surgery | Q84436167 | ||
Immediate definitive prosthetic reconstruction in patients with ptotic breasts | Q84740781 | ||
AlloDerm Performance in the Setting of Prosthetic Breast Surgery, Infection, and Irradiation | Q84973984 | ||
Discussion: A paradigm shift in U.S. breast reconstruction: increasing implant rates | Q85799857 | ||
Rib osteomyelitis: an uncommon complication of breast implant infection | Q86166300 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 161-172 | |
P577 | publication date | 2016-09-01 | |
P1433 | published in | Breast Cancer: Targets and Therapy | Q15816526 |
P1476 | title | Reducing infection risk in implant-based breast-reconstruction surgery: challenges and solutions | |
P478 | volume | 8 |
Q52591902 | Current Approaches Including Novel Nano/Microtechniques to Reduce Silicone Implant-Induced Contracture with Adverse Immune Responses. |
Q52597500 | Efficacy of Vancomycin-based Continuous Triple Antibiotic Irrigation in Immediate, Implant-based Breast Reconstruction. |
Q96128342 | Injectable and in situ crosslinkable gelatin microribbon hydrogels for stem cell delivery and bone regeneration in vivo |
Q41993238 | Surveillance and Prevention of Surgical Site Infections in Breast Oncologic Surgery with Immediate Reconstruction |
Q57495612 | The Impact of Closed Incision Negative Pressure Therapy on Postoperative Breast Reconstruction Outcomes |
Q57822267 | The Role of Antibiotics in Breast Pocket Irrigation and Implant Immersion: A Systematic Review |
Search more.